Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Low-Dose Pioglitazone in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04501406 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT04501406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Low-Dose Pioglitazone in Patients With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Recruiting
Start date
December 15, 2020
Completion date
August 31, 2027
Enrollment
166 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis, type 2 diabetes mellitus (t2dm)